Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging

Michael S. Hofman, Amir Iravani, Tatenda Nzenza, Declan G. Murphy

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Radiolabeled prostate-specific membrane antigen PET (PSMA PET) is emerging as an important modality for imaging prostate cancer (PCa). Promising clinical experience has led to increasing number of studies exploring the role of PSMA PET in different aspects of PCa including primary detection, risk stratification, targeted biopsy, initial staging, restaging at biochemical recurrence, biologic characterization, treatment response assessment and prognostication. PSMA PET may prove an important disease biomarker, expand our understanding of the pathogenesis and pave the way for personalized management of PCa.

Original languageEnglish
Pages (from-to)503-524
Number of pages22
JournalUrologic Clinics of North America
Volume45
Issue number3
DOIs
StatePublished - Aug 2018

Keywords

  • PET
  • PSMA PET
  • PSMA PET/CT
  • Prostate cancer
  • Prostate-specific membrane antigen

Fingerprint

Dive into the research topics of 'Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging'. Together they form a unique fingerprint.

Cite this